Company: HQL
Filing Date: 2025-04-14
Form Type: DEF 14A
Source: 0001104659-25-034659
Chunk: 6

Company: abrdn Life Sciences Investors
Filing Date: 2025-04-14
Form: DEF 14A
Chunk 6
---
 account statement from the person's broker, (3) persons who have been granted proxies, and (4) such other persons that we, in our sole discretion, may elect to admit. To gain admittance, if you are a shareholder of record or a proxy holder

<div align='center'>4</div>

of a shareholder of record, you must bring a form of personal identification to the Meeting, where your name will be verified against our shareholder list. If a broker or other nominee holds your shares and you plan to attend a Meeting, you should bring a recent brokerage statement showing your ownership of the shares, as well as a form of personal identification. If you are a beneficial owner and plan to vote at a Meeting, you should also bring a proxy card from your broker. Each Board has fixed the close of business on April 7, 2025 as the Record Date for the determination of shareholders entitled to notice of, and to vote at, each Meeting and at any adjournment or postponement thereof. Each Fund has one class of shares, par value $0.01 per share. Each share of a Fund is entitled to one vote at the Meeting, and fractional shares are entitled to a proportionate share of one vote. On the Record Date, the following number of shares of each Fund were issued and outstanding:

| HQH |     | 53,862,184.0 |
| HQL |     | 28,872,416.0 |
| THQ |     | 41,379,166.7 |
| THW |     | 39,849,957.6 |

Important Notice Regarding the Availability of Proxy Materials for the Meetings to Be Held on Wednesday, May 28, 2025: The Proxy Materials and each Fund's most recent annual report for the fiscal year ended September 30, 2024 are available on the Internet at https://www.abrdnhqh.com (for HQH) https://www.abrdnhql.com (for HQL) https://www.abrdnthq.com (for THQ) and https://www.abrdnthw.com (for THW). Each Fund will furnish, without charge, a copy of its annual report for the fiscal year ended September 30, 2024 and any more recent reports, to any Fund shareholder upon request. To request a copy, please write to the Funds c/o abrdn Inc., 1900 Market Street, Suite 200, Philadelphia, PA 19103, or call